top of page

Molecular Agronomy: An Innovative Strategy for Sustainable Crop Protection

EPICS Biotechnology is a biotechnology company developing plant-derived biocontrols to support a more sustainable and cost-effective crop input market. Our platform unlocks complex plant bioactives to complement integrated pest management (IPM) strategies.

​

Rather than replacing existing tools, we aim to reduce reliance on chemical inputs and energy-intensive fermentation, while addressing resistance challenges tied to simplified practices like herbicide-tolerant GM crops. EPICS empowers partners to build more resilient, diversified crop protection programs with proven bioactives in development or already in use but facing regulatory and economic pressure.

Farming Field
Logo-Text-Blanc (1)_edited_edited.png

We are Molecular Agonomists

Who We Are

At EPICS Biotechnology, we are pioneering at the intersection of biotech and agriculture.

 

We use protein engineering and gene editing to unlock bioactive compounds in plants—aiming to deliver desirable traits to producers with speed, low cost, and scalability in mind. 

 

By using plants as natural biofactories to produce high-value bioactives, we’re exploring next-generation crop inputs designed to be sustainable, scalable, and symbiotic with nature. With each seed, we aim to grow more than food—we aim to grow solutions.

The Problem

Modern agriculture is constrained by a fundamental design flaw: delivery inefficiency.

Up to 80% of sprayed active ingredients are lost before they ever reach their target—due to rain wash-off, UV degradation, and wind drift.

​

This is not only an environmental challenge, but a significant economic burden, contributing to an estimated $25–40 billion in annual losses.

 

The issue is not the availability of effective molecules—it is how they are delivered, retained, and activated in real-world conditions.

Logo-Text-Blanc (1)_edited_edited.png

50%

lost during chemical application

Logo-Text-Blanc (1)_edited_edited.png

50–80%

of active ingredients never reach their target*

website image.png
Logo-Text-Blanc (1)_edited_edited.png

$25–40B

annual loss due to crop protection inefficiency

*Key contributing factors:

  • Rain: Wash-off immediately post-application

  • Sun: UV exposure reduces activity

  • Wind: Drift, volatilization, and off-target movement

*Sources : Fernández et al., Crop Protection (2014), Holloway et al., Pest Management Science (2008), EPA Spray Drift Report (US EPA), (Phillips McDougall, Agbio Investor, FAO)

Our Solution

Using a Molecular Agronomy approach, EPICS has developed a seed-based expression system designed to produce high-value biopesticides and biostimulants—naturally, at scale, with the potential to lower input costs for growers.

 

Our plants are designed to express complex biofunctional proteins directly in their seeds, reducing reliance on synthetic chemicals or microbial fermentation.

 

Once harvested, these seeds are designed to degrade naturally over time, without leaving chemical residues or altering the genetics of treated plants —with the goal of supporting crop protection, yield potential, and long-term soil health.

AEnB2UrZ4iSAC-Wlf3islsKHJw7NbQjIu7TML5TSESnHNplKJExY4z_mgxvN6AdTUKa8HBIyfIMheLXAPybV6M14Mk
Logo-Text-Blanc (1)_edited_edited.png

​If delivery is the challenge, it can
also be the solution

Filmaxâ„¢ Multipurpose Bioadjuvant

Filmax™ accelerates formulation development by enabling rapid mixing, compatibility assessments, and co‑formulation of proven or already registered biologicals and chemicals. This shortens development timelines and supports faster market entry while improving efficacy, stability, and environmental footprint. Our first Filmax product is currently advancing into Phase V, as a natural organic adjuvant, within the EPICS portfolio.

​

Performance simulations demonstrate improved adhesion, retention, and rain‑fastness on leaf surfaces following post‑emergence foliar application. Additional testing shows that Filmax‑enabled adjuvant systems can reduce the effective dose of certain actives by up to 60 percent at low use rates, highlighting both cost efficiency with field‑level impact.

​

Screenshot 2026-04-17 121524.png
filmax3.png

Our Partners

Supported by a world-class innovation network.

5.png
65ca49277ad4e85462b11018_bgi-logo.png
65ca49277ad4e85462b11018_bgi-logo_edited
3_edited.png
logo Dotomics.jpg
bottom of page